Modifications and Competitors
| Peptide | Modifications of HBP-1 and competitors | % binding* | Competition* |
|---|---|---|---|
| HBP-1 | S-P-R-G-D-L-A-V-L-G-H-K-Y | 11.1% | 99.9% |
| HBP-AGA | S-P-A-G-A-L-A-V-L-G-H-K-Y | 0.2% | |
| HBP-AXXA | S-P-R-G-D-A-A-V-A-G-H-K-Y | 0.2% | |
| TP H2009.1 | R-G-D-L-A-T-L-R-Q-L-A-Q-E-D-G-V-V-G-V-R-Y | 99.9% | |
| A20FMDV2 | N-A-V-P-N-L-R-G-D-L-Q-V-L-A-Q-K-V-A-R-T-Y | 99.9% | |
| c-RGD | cyclo-(R-G-D-d-F-V) | 99.8% |
↵* Applied dose per 106 cells.